In Vivo Gene Editing for the Treatment of Squamous Cell Carcinomas, a Direct Platform Approach
- CRISPR directed gene editing of master regulator genes controlling oncogenesis in cutaneous squamous cell carcinoma
- Tumor cell specific disruption of NRF2 and EGFR genes as a platform approach to the treatment of squamous cell carcinoma of the lung
- Direct delivery strategies for enhancing the effectiveness of gene editing in cancer treatment